Liu R, Fan M, Candas D, Qin L, Zhang X, Eldridge A, et al
In a recent learning network event by MBGH titled "Obesity, the Employer Conundrum," a session focused on how employers make informed decisions regarding the coverage of GLP-1 weight loss medications, with a particular emphasis on semaglutide as the most prescribed GLP-1
While everolimus has shown promise in modulating the immune response and improving TB treatment outcomes, there are significant concerns about long-term use due to its immunosuppressive effects
The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial
What happens to my hunger and appetite within the first week after stopping semaglutide
A unique feature of the PDO model is that it can be developed from both tumor and healthy tissues from the same patient, allowing drug selectivity for tumor cells to be assessed